10
Views
1
CrossRef citations to date
0
Altmetric
Review

Polymorphous light eruption, chronic actinic dermatitis, solar urticaria and porphyria cutanea tarda

Pages 271-278 | Published online: 10 Jan 2014

References

  • Fotiades J, Soter NA, Lim HW. Results of evaluation of 203 patients for photosensitivity in a 7.3-year period. J. Am. Acad. Dermatol.33, 597–602 (1995).
  • Crouch RB, Foley PA, Baker CS. Analysis of patients with suspected photosensitivity referred for investigation to an Australian photodermatology clinic. J. Am. Acad. Dermatol.48(5), 714–720 (2003).
  • Stratigos AJ, Antoniou C, Papathanakou E et al. Spectrum of idiopathic photodermatoses in a Mediterranean country. Int. J. Dermatol.42(6), 449–454 (2003).
  • Wong SN, Khoo LS. Analysis of photodermatoses seen in a predominantly Asian population at a photodermatology clinic in Singapore. Photodermatol. Photoimmunol. Photomed.21(1), 40–44 (2005).
  • Kontos A, Cusack C, Chaffins M, Lim HW. Polymorphous light eruption in African-Americans: pinpoint popular variant. Photodermatol. Photoimmunol. Photomed.18, 303–306 (2002).
  • Hasan T, Ranki A, Jansen CT, Karvonen J. Disease associations in polymorphous light eruption. A long-term follow-up study of 94 patients. Arch. Dermatol.134(9), 1081–1085 (1998).
  • Hasan T, Nyberg F, Stephansson E et al. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings. Br. J. Dermatol.136(5), 699–705 (1997).
  • Nyberg F, Hasan T, Puska P et al. Occurrence of polymorphous light eruption in lupus erythematosus. Br. J. Dermatol.136(2), 217–221 (1997).
  • Das S, Lloyd JJ, Walshaw D, Farr PM. Provocation testing in polymorphic light eruption using fluorescent untraviolet (UV) A and UVB lamps. Br. J. Dermatol.151, 1066–1070 (2004).
  • Van de Pas CB, Kelly DA, Seed PT, Young AR, Hawk JL, Walker SL. Ultraviolet-radiation-induced erythema and suppression of contact hypersensitivity responses in patients with polymorphic light eruption. J. Invest. Dermatol.122(2), 295–299 (2004).
  • Man I, Dawe RS, Ferguson J. Artificial hardening for polymorphic light eruption: practical points from ten years’ experience. Photodermatol. Photoimmunol. Photomed.15(3–4), 96–99 (1999).
  • Tuchinda C, Lim HW, Osterwalder U, Rougier A. Novel emerging sunscreen technologies. Dermatol. Clin.24, 105–117 (2006).
  • Gonzalez S, Pathak MA, Cuevas J, Villarrubia VG, Fitzpatrick TB. Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin. Photodermatol. Photoimmunol. Photomed.13(1–2), 50–60 (1997).
  • Kullavanijaya P, Lim HW. Photoprotection. J. Am. Acad. Dermatol.52, 937–958 (2005).
  • Dawe RS, Crombie IK, Ferguson J. The natural history of chronic actinic dermatitis. Arch. Dermatol.136(10), 1215–1220 (2000).
  • Lim HW, Morison W, Kamide R, Buchness MR, Harris R, Soter NA. Chronic actinic dermatitis: an analysis of 51 patients evaluated in the United States and Japan. Arch. Dermatol.130, 1284–1289 (1994).
  • Meola T, Sanchez M, Lim HW, Buchness MR, Soter NA. Chronic actinic dermatitis associated with human immunodeficiency virus infection. Br. J. Dermatol.137, 431–436 (1997).
  • Wong SN, Khoo SW. Human immunodeficiency virus infection presenting with chronic actinic dermatitis: a case report. Ann. Acad. Med. Singapore30(6), 664–667 (2001).
  • Heller P, Wieczorek R, Waldo E et al. Chronic actinic dermatitis: an immunohistochemical study of its T cell antigenic profile with comparison to cutaneous T cell lymphoma. Am. J. Dermatopath.16, 510–516 (1994).
  • Lim HW, Cohen D, Soter NA. Chronic actinic dermatitis: results of patch and photopatch tests with Compositae, fragrances and pesticides. J. Am. Acad. Dermatol.38, 108–111 (1998).
  • Menage HD, Harrison GI, Potten CS, Young AR, Hawk JL. The action spectrum for induction of chronic actinic dermatitis is similar to that for sunburn inflammation. Photochem. Photobiol.62(6), 976–979 (1995).
  • Menage Hdu P, Sattar NK, Haskard DO, Hawk JL, Breathnach SM. A study of the kinetics and pattern of E-selectin, VCAM-1 and ICAM-1 expression in chronic actinic dermatitis. Br. J. Dermatol.134(2), 262–268 (1996).
  • Nousari H, Anhalt GJ, Morison WL. Mycophenolate in psoralen-UV-A desensitization therapy for chronic actinic dermatitis. Arch. Dermatol.135(9), 1128–1129 (1999).
  • Uetsu N, Okamoto H, Fujii K, Doi R, Horio T. Treatment of chronic actinic dermatitis with tacrolimus ointment. J. Am. Acad. Dermatol.47(6), 881–884 (2002).
  • Beattie PE, Dawe RS, Ibbotson SH, Ferguson J. Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases. Arch. Dermatol.139(9), 1149–1154 (2003).
  • Uetsu N, Miyauchi-Hashimoto H, Okamoto H, Horio T. The clinical and photobiological characteristics of solar urticaria in 40 patients. Br. J. Dermatol.142(1), 32–38 (2000).
  • Monfrecola G, Masturzo E, Riccardo AM, Balato F, Ayala F, Di Costanzo MP. Solar urticaria: a report on 57 cases. Am. J. Contact Dermatol.11(2), 89–94 (2000).
  • Simons FE. Advances in H1-antihistamines. N. Engl. J. Med.351(21), 2203–2217 (2004).
  • Beissert S, Stander H, Schwarz T. UVA rush hardening for the treatment of solar urticaria. J. Am. Acad. Dermatol.42(6), 1030–1032 (2000).
  • Darras S, Segard M, Mortier L, Bonnevalle A, Thomas P. Treatment of solar urticaria by intravenous immunoglobulins and PUVA therapy. Ann. Dermatol. Venereol.131, 65–69 (2004).
  • Held JL, Sassa S, Kappas A, Harber LC. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients. J. Invest. Dermatol.93(3), 332–334 (1989).
  • Mendez M, Rossetti MV, Del C Battle AM, Parera VE. The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population. J. Am. Acad. Dermatol.52(3 Pt 1), 417–424 (2005).
  • Elder GH. Porphyria cutanea tarda. Semin. Liver Dis.18(1), 67–75 (1998).
  • Stenson PD, Ball EV, Mort M et al. Human Gene Mutation Database (HGMD): 2003 update. Hum. Mutat.21(6), 577–581 (2003).
  • Lim HW. Pathophysiology of photosensitivity in the cutaneous porphyrias. J. Invest. Dermatol.124, xvi–xvii (2005).
  • Shieh S, Cohen JL, Lim HW. Management of porphyria cutanea tarda in the setting of chronic renal failure: A case report and review. J. Am. Acad. Dermatol.42, 645–652 (2000).
  • Richard E, Mendez M, Mazurier F et al. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection. Mol. Ther.4(4), 331–338 (2001).
  • Fontanellas A, Mendez M, Mazurier F et al. Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells. Gene Ther.8(8), 618–626 (2001).
  • Fontanellas A, Mazurier F, Moreau-Gaudry F, Belloc F, Ged C, de Verneuil H. Correction of uroporphyrinogen decarboxylase deficiency (hepatoerythropoietic porphyria) in Epstein-Barr virus-transformed B-cell lines by retrovirus-mediated gene transfer: fluorescence-based selection of transduced cells. Blood94(2), 465–474 (1999).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.